At the KMIS meeting (Klinisch-Mikrobiologisch-Infektiologisches Symposium)
on Dec. 3-5, 2009 in Berlin, Bruker
Daltonics announces a framework agreement with Synlab concerning molecular
microbial identification based on MALDI-TOF mass spectrometry. Synlab is a European
private diagnostic laboratory association, and Bruker Daltonics is the worldwide
leading provider of mass spectrometry-based microorganism identification solutions.
Synlab currently has more than 70 diagnostic laboratories in Germany and other
European countries.
Synlab and Bruker have concluded a long-term partnership agreement in order
to equip the laboratories of the Synlab association exclusively with the MALDI
Biotyper system for fast and reliable molecular microbial identification. The
MALDI Biotyper is currently already in routine use in Synlab’s clinical
microbiology centers in Trier, Weiden and Dachau in Germany. Moreover, Bruker
and Synlab intend to further enlarge and refine the MALDI Biotyper reference
library using well defined clinical isolates from the daily microbiology routine
work of the Synlab laboratories.
The MALDI Biotyper is integrated into the Synlab laboratories’ microbiology
workflow, combining fast molecular identification with conventional antibiotic
susceptibility testing (AST). The MALDI Biotyper reports the identification
results into the existing laboratory information systems (LIS). Integration
with LIS MCS (www.mcs-ag.com), Medat (www.medat.de) and Vision4health (www.vision4health.com)
has already been established for Synlab, while integration with other LIS providers
is also possible.
Dr. Ulrich Knipp, Technical Head of Microbiology at Synlab in Trier, commented:
“After evaluating the MALDI Biotyper very thoroughly within the Synlab
group, we are convinced that Bruker Daltonics is the most reliable partner for
microbial identification based on mass spectrometry, and is providing outstanding
microbiological service and support. Bruker Daltonics is fully established in
the clinical microbiology market, and the MALDI Biotyper fulfils our requirements
for reliability and robustness. The MALDI Biotyper represents a clear milestone
substantiating our high quality molecular microbiology diagnostics.”
Dr. Guido Mix, Director of Microbiology at Bruker Daltonics, added: “We
are very pleased that our MALDI Biotyper fulfils the high demands of leading
clinical laboratories like Synlab. Our framework contract with Synlab validates
our efforts to provide comprehensive service and applications support to our
customers by our dedicated microbiologists, fully developed technicians network
and dedicated IT specialists for integration into various laboratory information
systems (LIS).”